Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis.

PubWeight™: 3.57‹?› | Rank: Top 1%

🔗 View Article (PMID 8543308)

Published in Hum Pathol on January 01, 1996

Authors

H M el-Zimaity1, D Y Graham, M T al-Assi, H Malaty, T J Karttunen, D P Graham, R M Huberman, R M Genta

Author Affiliations

1: Department of Medicine, Veterans Affairs Medical Center, Houston, TX 77030, USA.

Articles citing this

Helicobacter pylori. Clin Microbiol Rev (1997) 9.22

Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13

Helicobacter pylori detection and antimicrobial susceptibility testing. Clin Microbiol Rev (2007) 3.43

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy (2011) 2.64

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut (1999) 1.72

Helicobacter pylori outer membrane proteins and gastroduodenal disease. Gut (2005) 1.62

Challenge model for Helicobacter pylori infection in human volunteers. Gut (2004) 1.57

Rapid quantitative assessment of gastric corpus atrophy in tissue sections. J Clin Pathol (2001) 1.50

Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patients. Gut (2006) 1.45

Small organism, many challenges. Hum Pathol (1996) 1.41

Helicobacter pylori and gastric cancer:current status of the Austrain Czech German gastric cancer prevention trial (PRISMA Study). World J Gastroenterol (2001) 1.35

Fast and accurate quantitative detection of Helicobacter pylori and identification of clarithromycin resistance mutations in H. pylori isolates from gastric biopsy specimens by real-time PCR. J Clin Microbiol (2003) 1.23

Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol (2014) 1.18

Gastric intestinal metaplasia: subtypes and natural history. J Clin Pathol (2001) 1.17

Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol (1999) 1.14

Role of deletion located between the intermediate and middle regions of the Helicobacter pylori vacA gene in cases of gastroduodenal diseases. J Clin Microbiol (2009) 1.13

Gastric mucosal interleukin-17 and -18 mRNA expression in Helicobacter pylori-induced Mongolian gerbils. Cancer Sci (2009) 1.09

Helicobacter pylori BabA expression, gastric mucosal injury, and clinical outcome. Clin Gastroenterol Hepatol (2006) 1.08

The intact dupA cluster is a more reliable Helicobacter pylori virulence marker than dupA alone. Infect Immun (2011) 1.06

Consequences of Helicobacter pylori infection in children. World J Gastroenterol (2010) 1.03

Gastric precancerous lesions: heading for an international consensus. Gut (1999) 1.01

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Virchows Arch (2011) 0.99

Effects of blood group antigen-binding adhesin expression during Helicobacter pylori infection of Mongolian gerbils. J Infect Dis (2011) 0.99

Genotypic, clinical, and demographic characteristics of children infected with Helicobacter pylori. J Clin Microbiol (2001) 0.97

Epidemiological trends of pre-malignant gastric lesions: a long-term nationwide study in the Netherlands. Gut (2007) 0.97

Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch (2014) 0.96

homB status of Helicobacter pylori as a novel marker to distinguish gastric cancer from duodenal ulcer. J Clin Microbiol (2009) 0.95

Interobserver variation in histopathological assessment of Helicobacter pylori gastritis. World J Gastroenterol (2003) 0.94

Gastric atrophy, diagnosing and staging. World J Gastroenterol (2006) 0.93

Relationship between Helicobacter pylori hopQ genotype and clinical outcome in Asian and Western populations. J Gastroenterol Hepatol (2009) 0.89

Helicobacter pylori outer membrane proteins on gastric mucosal interleukin 6 and 11 expression in Mongolian gerbils. J Gastroenterol Hepatol (2011) 0.88

The gastric cardia in gastro-oesophageal disease. J Clin Pathol (2000) 0.86

Acid suppression and gastric atrophy: sifting fact from fiction. Gut (1998) 0.85

Helicobacter pylori infection and long term proton pump inhibitor therapy. Gut (2004) 0.85

Pre-treatment urea breath test results predict the efficacy of Helicobacter pylori eradication therapy in patients with active duodenal ulcers. World J Gastroenterol (2004) 0.85

Refinement and reproducibility of histologic criteria for the assessment of microscopic lesions in patients with gastroesophageal reflux disease: the Esohisto Project. Dig Dis Sci (2011) 0.84

Prevalence and risk factors of atrophic gastritis and intestinal metaplasia: a nationwide multicenter prospective study in Korea. Gut Liver (2013) 0.83

Role of Helicobacter pylori plasticity region genes in development of gastroduodenal diseases. J Clin Microbiol (2011) 0.82

Comparison of five diagnostic methods for Helicobacter pylori. Iran J Microbiol (2013) 0.81

Gastric biopsies: the gap between evidence-based medicine and daily practice in the management of gastric Helicobacter pylori infection. Can J Gastroenterol (2013) 0.80

NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite. Dig Dis Sci (2002) 0.79

Does gastric atrophy exist in children? World J Gastroenterol (2006) 0.79

Can endoscopic atrophy predict histological atrophy? Historical study in United Kingdom and Japan. World J Gastroenterol (2015) 0.79

Intracellular VacA is a valuable marker to predict whether Helicobacter pylori induces progressive atrophic gastritis that is associated with the development of gastric cancer. Dig Dis Sci (2005) 0.78

High Prevalence of Gastric Preneoplastic Lesions in East Asians and Hispanics in the USA. Dig Dis Sci (2015) 0.78

A reliable method for the simultaneous identification of H pylori and gastric metaplasia in the duodenum. J Clin Pathol (1999) 0.77

Atrophic progression induced by H. pylori infection is correlated with a changing pepsinogen I value and associated with the development of gastric cancer. Dig Dis Sci (2004) 0.77

Expression of angiotensin II type 1 and type 2 receptor mRNAs in the gastric mucosa of Helicobacter pylori-infected Mongolian gerbils. J Gastroenterol (2011) 0.77

Helicobacter pylori with the Intact dupA Cluster is more Virulent than the Strains with the Incomplete dupA Cluster. Curr Microbiol (2015) 0.76

Modified Genta triple stain for identifying Helicobacter pylori. J Clin Pathol (1999) 0.75

Diagnosis of Helicobacter pylori by invasive test: histology. Ann Transl Med (2015) 0.75

CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer. J Clin Pathol (2005) 0.75

Validation of a High-Throughput Multiplex Genetic Detection System for Helicobacter pylori Identification, Quantification, Virulence, and Resistance Analysis. Front Microbiol (2016) 0.75

[Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems]. Pan Afr Med J (2016) 0.75

Atrophic gastritis: Helicobacter pylori versus duodenogastric reflux. Clujul Med (2013) 0.75

Imprint cytology: a simple, cost effectiveness analysis for diagnosing Helicobacter pylori, in west of Iran. Med J Islam Repub Iran (2012) 0.75

Helicobacter pylori-induced damage to the gastric mucosa is not modulated by previous vagotomy or medical treatment of peptic ulcer disease: a comparative study of vagotomized patients, medically treated peptic ulcer patients and community control subjects. World J Surg (2008) 0.75

The serum pepsinogen levels for risk assessment of gastric neoplasms: New proposal from a case-control study in Korea. Medicine (Baltimore) (2017) 0.75

Articles by these authors

Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol (1996) 21.37

Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugs. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (1995) 9.77

Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein. J Virol (1992) 8.35

Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther (2002) 6.17

Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrob Agents Chemother (1996) 6.01

Norwalk virus genome cloning and characterization. Science (1990) 5.83

Campylobacter pylori detected noninvasively by the 13C-urea breath test. Lancet (1987) 5.02

Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol (1981) 4.87

In vitro transcription and translation of simian rotavirus SA11 gene products. J Virol (1980) 4.40

Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. JAMA (1999) 4.25

Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol (1999) 4.13

Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology (1998) 4.12

Detection of Norwalk virus in stool by polymerase chain reaction. J Clin Microbiol (1992) 3.82

A sensitive and specific serologic test for detection of Campylobacter pylori infection. Gastroenterology (1989) 3.66

A M(r) 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A (2000) 3.66

The course of patients after variceal hemorrhage. Gastroenterology (1981) 3.33

Population genetic analysis of Helicobacter pylori by multilocus enzyme electrophoresis: extensive allelic diversity and recombinational population structure. J Bacteriol (1996) 3.32

Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases. J Clin Microbiol (1998) 3.31

Colorectal carcinoma associated with serrated adenoma--prevalence, histological features, and prognosis. J Pathol (2001) 3.24

Allelic variation in the cagA gene of Helicobacter pylori obtained from Korea compared to the United States. Am J Gastroenterol (1996) 3.20

N-acetylneuraminyllactose-binding fibrillar hemagglutinin of Campylobacter pylori: a putative colonization factor antigen. Infect Immun (1988) 3.16

Water source as risk factor for Helicobacter pylori infection in Peruvian children. Gastrointestinal Physiology Working Group. Lancet (1991) 3.09

Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology (1992) 3.02

Gastric lymphoid follicles in Helicobacter pylori infection: frequency, distribution, and response to triple therapy. Hum Pathol (1993) 2.96

Ultrastructural localization of rotavirus antigens using colloidal gold. Virus Res (1984) 2.95

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population. Gastroenterology (1992) 2.83

Identification, synthesis, and modifications of simian rotavirus SA11 polypeptides in infected cells. J Virol (1982) 2.67

A plaque assay for the simian rotavirus SAII. J Gen Virol (1979) 2.65

A PCR-oligonucleotide ligation assay to determine the prevalence of 23S rRNA gene mutations in clarithromycin-resistant Helicobacter pylori. Antimicrob Agents Chemother (1997) 2.63

Frequency of positive tests for cytomegalovirus in AIDS patients: endoscopic lesions compared with normal mucosa. Am J Gastroenterol (1993) 2.63

Variceal hemorrhage: a critical evaluation of survival analysis. Gastroenterology (1982) 2.60

Recombinant Norwalk virus-like particles given orally to volunteers: phase I study. Gastroenterology (1999) 2.54

Rotavirus stability and inactivation. J Gen Virol (1979) 2.48

Point mutations in the 23S rRNA gene of Helicobacter pylori associated with different levels of clarithromycin resistance. J Antimicrob Chemother (1997) 2.47

Helicobacter pylori infection: genetic and environmental influences. A study of twins. Ann Intern Med (1994) 2.47

Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH. Gastroenterology (1999) 2.44

Patients, payers, and paradigm shifts: what to do about Helicobacter pylori. Am J Gastroenterol (1996) 2.43

Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome. Helicobacter (1998) 2.39

Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates. Clin Infect Dis (1998) 2.38

Fundic gland polyps developing during omeprazole therapy. Am J Gastroenterol (1997) 2.37

Comparison of biopsy sites for the histopathologic diagnosis of Helicobacter pylori: a topographic study of H. pylori density and distribution. Gastrointest Endosc (1994) 2.36

Cimetidine, cigarette smoking, and recurrence of duodenal ulcer. N Engl J Med (1984) 2.29

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain. Hum Pathol (1994) 2.16

Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut (1994) 2.14

Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13

Pancreatic-biliary ascariasis: experience of 300 cases. Am J Gastroenterol (1997) 2.10

Mycobacteria and inflammatory bowel disease. Results of culture. Gastroenterology (1987) 2.07

Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut (1992) 2.06

Nucleic acid hybridization studies of mycobactin-dependent mycobacteria. J Clin Microbiol (1988) 2.06

Gastroduodenal mucosa and dyspeptic symptoms in arthritic patients during chronic nonsteroidal anti-inflammatory drug use. Am J Gastroenterol (1987) 2.05

Mucosal pathology of the foregut associated with food allergy and recurrent abdominal pains in children. Acta Paediatr (2001) 2.02

Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol (1993) 2.00

Immunohistochemical study of colorectal tumors for expression of a novel transmembrane carbonic anhydrase, MN/CA IX, with potential value as a marker of cell proliferation. Am J Pathol (1998) 1.99

Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries. Epidemiol Infect (2000) 1.97

Characterization of a Helicobacter pylori neutrophil-activating protein. Infect Immun (1995) 1.97

Helicobacter pylori in the drinking water in Peru. Gastroenterology (1996) 1.95

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther (2002) 1.94

Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction. J Clin Microbiol (1993) 1.94

Detection of Mycobacterium avium subspecies paratuberculosis in Crohn's diseased tissues by in situ hybridization. Am J Gastroenterol (2001) 1.93

Helicobacter pylori infection produces reversible glycosylation changes to gastric mucins. Virchows Arch (1998) 1.91

Noninvasive detection of Helicobacter pylori infection in clinical practice: the 13C urea breath test. Am J Gastroenterol (1996) 1.89

Antibiotic treatment of gastric lymphoma of mucosa-associated lymphoid tissue. An uncontrolled trial. Ann Intern Med (1999) 1.88

Biochemical mapping of the simian rotavirus SA11 genome. J Virol (1983) 1.88

Letter: the ethics of using inferior regimens in H. pylori randomised trials. Aliment Pharmacol Ther (2012) 1.87

Cloning, nucleotide sequence, and expression of a gene encoding an adhesin subunit protein of Helicobacter pylori. J Bacteriol (1993) 1.85

Factors influencing the epidemiology of Helicobacter pylori infection in children. Pediatrics (1991) 1.82

Microsatellite instability: impact on cancer progression in proximal and distal colorectal cancers. Eur J Cancer (1999) 1.82

Stage-dependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer (2012) 1.82

Serum CagA antibodies in asymptomatic subjects and patients with peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol (1996) 1.81

Proteolytic enhancement of rotavirus infectivity: biology mechanism. Virology (1980) 1.81

Ultrastructural study of rotavirus replication in cultured cells. J Gen Virol (1980) 1.81

Campylobacter pyloridis gastritis: the past, the present, and speculations about the future. Am J Gastroenterol (1987) 1.80

The who's and when's of therapy for Helicobacter pylori. Am J Gastroenterol (1990) 1.79

Simian rotavirus SA11 replication in cell cultures. J Virol (1979) 1.79

Prospective randomized comparison of polyvinyl bougies and through-the-scope balloons for dilation of peptic strictures of the esophagus. Gastrointest Endosc (1995) 1.78

Unsaturated fatty acids and viability of Helicobacter (Campylobacter) pylori. J Clin Microbiol (1990) 1.78

Aspirin and the stomach. Ann Intern Med (1986) 1.77

Detection of antigenically distinct rotaviruses from infants. Infect Immun (1983) 1.77

Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis. Scand J Gastroenterol (1997) 1.76

Costs of diagnosis and treatment of Helicobacter pylori infection: when does choosing the treatment regimen based on susceptibility testing become cost effective? Am J Gastroenterol (1999) 1.76

The molecular epidemiology of rotavirus gastroenteritis. Prog Med Virol (1984) 1.74

Sensitivity of the esophageal mucosa to pH in gastroesophageal reflux disease. Gastroenterology (1989) 1.74

Adherence and internalization of Helicobacter pylori by HEp-2 cells. Gastroenterology (1992) 1.74

The role of Microsporidia in the pathogenesis of HIV-related chronic diarrhea. Ann Intern Med (1993) 1.73

Relation between clinical presentation, Helicobacter pylori density, interleukin 1beta and 8 production, and cagA status. Gut (1999) 1.72

Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach. Dig Dis Sci (2000) 1.71

Urease-associated heat shock protein of Helicobacter pylori. Infect Immun (1992) 1.71

Possible role of Helicobacter pylori infection in early gastric cancer development. Cancer (1994) 1.68

Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68

The Sydney System revisited: the Houston International Gastritis Workshop. Am J Gastroenterol (1995) 1.68

Misoprostol compared with sucralfate in the prevention of nonsteroidal anti-inflammatory drug-induced gastric ulcer. A randomized, controlled trial. Ann Intern Med (1991) 1.68

Toothpick perforation of the intestines. Ann Surg (1977) 1.67